DEERFIELD, Ill. July 2, 2008 - Siemens Healthcare Diagnostics received CE marking approval to sell the hepatitis B virus e-antigen (HBeAg) and antibody to the hepatitis B virus (anti-HBe) tests in the European marketplace. More

MALVERN, Pa., June 23, 2008 - The Premier healthcare alliance Purchasing Partners division recently announced that Siemens Healthcare Diagnostics (www.siemens.com/diagnostics) was one of 15 winners chosen for the Pinnacle Award out of more than 800 eligible suppliers, representing the top two percent of healthcare equipment suppliers. More

DEERFIELD, IL. May 8, 2008 - Siemens Healthcare and Laboratory Corporation of America® Holdings (LabCorp®) today announced that they have entered a non-exclusive agreement to discuss future possibilities to co-develop new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology and diabetes. More

Donal Quinn has been appointed new head of the Diagnostics division of the Siemens Healthcare Sector. In his new position, Quinn succeeds Jim Reid-Anderson, who on May 1st became the new CEO of this sector. Prior to his new job, Quinn served as Executive Vice President and Chief Customer Officer of the Diagnostics division since November 2007. More

DEERFIELD, IL., Feb. 18, 2008 ― Siemens Healthcare (www.siemens.com/diagnostics) announced today that its VERSANT™ 440 Molecular System has been approved for marketing by the U.S. Food and Drug Administration (FDA) for use with the VERSANT HCV RNA 3.0 assay for management of HCV-infected patients undergoing antiviral therapy. More

Deerfield, IL, January 16, 2008  Siemens Healthcare Diagnostics, today announced that it has launched the LOCI® Folate, LOCI® B12, and LOCI® Ferritin tests for use on the Dimension Vista® 1500 Intelligent Lab System, an ultra-integrated chemistry analyzer More

DEERFIELD, IL, Dec. 20, 2007 – Siemens Medical Solutions Diagnostics today announced the introduction of the MicroScan® WalkAway® plus Systems for mid- and high-volume clinical diagnostic microbiology laboratories. More

Siemens has successfully completed the acquisition of Dade Behring Holdings, Inc. The laboratory diagnostics company joins the existing business of Siemens Medical Solutions Diagnostics. As the market leader in the attractive and rapidly growing field of in vitro diagnostics, Siemens now can offer its customers a unique and comprehensive healthcare solutions' portfolio, which brings together the entire medical imaging, laboratory diagnostics and clinical information technology (IT) value chain under one roof. More

Siemens Medical Solutions Diagnostics, a leader in the in vitro diagnostic industry, announced that they have signed an agreement with B-R-A-H-M-S Aktiengesellschaft for the rights to develop, produce and distribute a Procalcitonin assay used to assist with the early diagnosis of patients at risk for progression to severe sepsis. More

As the cash tender offer expired at 12:00 midnight on Oct. 31, 2007, Siemens intends to accept all validly tendered shares of U.S.-based laboratory diagnostics company Dade Behring. Siemens expects to close the transaction on or about Nov. 6, 2007. More